Michael Platten

Michael Platten is a Professor of Neurology and Chairman of the Department of Neurology at the University Hospital in Mannheim and Head of the Department of Neuroimmunology and Brain Tumor Immunology coordinator of the research topic Immunology and Cancer at the German Cancer Research Center in Heidelberg. He is the vice chair of the German Neurooncology Working Group (NOA) and serves on the Management Board of the Helmholtz Institute for Translational Oncology (HiTRON) and the Scientific Committee of the European Association of Neurooncology (EANO). Michael has received his MD from the University of Bonn, Germany and his postdoctoral training at the Universities of Tübingen, Germany and Stanford University. He and his team discovered novel pathways involved in immune regulation in gliomas and pioneered the development of novel therapeutic strategies for the immunotherapy of gliomas and other types of cancer and is currently conducting early multicenter trials testing these strategies. Michaels main scientific focus includes glioma immunogenicity, immune suppression, heterogeneity and personalized treatment strategies. He has published more than 350 articles in peer-reviewed journals including Nature, Nature Cancer, Nature Medicine, Science, Cancer Cell, PNAS, JCI, NEJM, Lancet Oncology and JCO and is listed as a Highly Cited Researcher.